Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
| Status: | Completed |
|---|---|
| Conditions: | Depression, Major Depression Disorder (MDD), Women's Studies |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Reproductive |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 4/21/2016 |
| Start Date: | June 2010 |
| End Date: | June 2014 |
The purpose of this study is to conduct a randomized pilot trial in a sample of 60 women who
meet criteria for Major Depressive Disorder (MDD) 1-18 months after a perinatal loss to
demonstrate the feasibility of the proposed recruitment methods and research design, of the
therapist training methods, and of delivering the adapted Interpersonal Psychotherapy group
treatment.
The investigators would like to examine preliminary evidence for the following hypotheses:
- Perinatal-loss specific IPT-G will be more acceptable to women who experience MDD
following perinatal loss than will Coping with Depression (CWD).
- Perinatal-loss specific IPT-G will result in reduced time to remission from MDD and
reduced depressive symptoms relative to CWD.
- Perinatal-loss specific IPT-G will result in increased social support and social
functioning, reduced couple distress, and reduced grief relative to CWD.
meet criteria for Major Depressive Disorder (MDD) 1-18 months after a perinatal loss to
demonstrate the feasibility of the proposed recruitment methods and research design, of the
therapist training methods, and of delivering the adapted Interpersonal Psychotherapy group
treatment.
The investigators would like to examine preliminary evidence for the following hypotheses:
- Perinatal-loss specific IPT-G will be more acceptable to women who experience MDD
following perinatal loss than will Coping with Depression (CWD).
- Perinatal-loss specific IPT-G will result in reduced time to remission from MDD and
reduced depressive symptoms relative to CWD.
- Perinatal-loss specific IPT-G will result in increased social support and social
functioning, reduced couple distress, and reduced grief relative to CWD.
Inclusion Criteria:
- Current Major Depressive episode.
- Experience perinatal loss 1-18 months prior to intake (including early and late fetal
death and the death of a live born neonate within the first 28 days).
Exclusion Criteria:
- Untreated thyroid difficulties (TSH levels out of the normal range).
- Anemia (hemoglobin or hematocrit out of the normal range).
- Onset of current major depressive episode prior to news of difficulties with the
pregnancy or health risk to the infant (women with prior episodes will be included).
- Current or past diagnosis of bipolar I disorder, schizophrenia or other psychotic
disorder.
- Primary diagnosis of substance dependence or eating disorder.
- Acute suicidal or homicidal risk.
- Non-stable course of antidepressant medication or psychotherapy (i.e., beginning or
changing dose of either within the previous 8 weeks).
- Any IPT or cognitive-behavioral treatment in the previous 8 weeks.
We found this trial at
1
site
Brown University Located in historic Providence, Rhode Island and founded in 1764, Brown University is...
Click here to add this to my saved trials
